References
- 1. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step // J Clin Oncol, 2000; 18(17):3144-50.
- 2. Bessel EM, Graus FF, Lopez-Guillermo A, et al. Primary non-Hodgkin`s lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long term survival and prognostic factors // Int J Radiat Oncol Biol Phys, 2004; 59(2):501-8.
- 3. Boiardi, A., A.Silvani, S.Valentini et al. Chemotherapy as first treatment for primary malignant non-Hodgkin`s lymphoma of central nervous system: preliminary data //J.Neurol, 1993; 241:96-100.
- 4. Brada M, Dearnaley D, Horwich A, Bloom HJ. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone // Int J Radiat Oncol Biol Phys, 1990; 18:787-792.
- 5. Central Brain Tumor Registry of the United States (2002). 2002 Statistical report: Primary Brain Tumors in the United States, 1995-1999. Published by the Central Brain Tumor Registry of the United States.
- 6. Chapin JE, Davis LE, Kornfeld M, Mandler RN. Neurologic manifestations of intravascular lymphomatosis// J Acta Neurol Scand, 1995; 91: 494-499.
- 7. Coté TR, Manns A, Hardy CR, et al. Epidemiology of brain lymphoma among people with or without acquired immune deficiency syndrome// J Natl Cancer Inst, 1996; 88:675 - 679.
- 8. DeAngelis L.M. Primary central nervous system lymphoma as a secondary malignancy// J Cancer, 1991; 67:1431-1435.
- 9. DeAngelis L.M. Primary central nervous system lymphoma imitates multiple sclerosis// J Neuro- Oncol, 1990; 9:177-181.
- 10. DeAngelis LM, Gutin PH, Leibel SA, et al. Intracranial tumors. Diagnosis and treatment. 1st edition. London: Martin Dunitz; 2002.
- 11. DeAngelis LM, Seiferheld W, Schold SC, et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10// J Clin Oncol, 2002; 20(24):4643-8.
- 12. Enrico C.Lallana and Lisa M. DeAngelis. Lymphomas and hemopoietic neoplasms// In: Textbook of Neuro-Oncology. Associate Editors Ossama Al- Mefty et al. Philadelphia: Elsevier Saunders, 2005; 301-309.
- 13. Ferreri AJM, Dell`Oro S, Foppoli M, et al. MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphoma//J Neurology, 2006; 66(9):1435-8.
- 14. Filipovich AH, Grimley MS. Immunodeficiency and cancer// In Abeloff, MD, Armitage JO, Lichter AS (eds): Clinical Oncology, 2nd ed. Philadelphia, Churchill Livingstone; 2000.
- 15. Grove A, Vyberg M. Primary leptomeningeal T-cell lymphoma: a case and a review of primary T-cell lymphomaof the central nervous system// Clin Neuropathol, 1993;12: 7-12.
- 16. Henry JM, Heffner RR Jr, Dillard SH et al. Primary malignant lymphomas of the central nervous system//J Cancer, 1974; 34:1293-1302.
- 17. Jaffe ES, Harris NL, Stein H, Vardiman JW eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Haemopoietic and Lymphoid Tissues// IARC Press: Lyon, 2001.
- 18. Kendra Peterson, Lisa M. DeAngelis. Primary cerebral lymphoma// In: Handbook of Clinical Neurology, Vol.24 (68): Neuro-Oncology, Part II. Ch.J. Vecht, editor; 1997; 257-268.
- 19. Küker W, Nägele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL):MRI features at presentation in 100 patients//J Neurooncol 2005; 72(2):169-77.
- 20. Liszka U, Drlicek M, Hitzenberger P et al. Intravascular lymphomatosis: a clinicopathological study of three cases// J Cancer Res Clin Oncol, 1994; 120: 164-168.
- 21. M.Deckert, W.Paulus Malignant lymphomas// In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissueis. Steven H. Swerdlow, International Agency for Research on Cancer, World Health Organization; 2008; 188-192.
- 22. Molnar PP, O`Neill BP, Scheithauer BW, Groothuis DR. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death//J Neuro-oncol, 1999; 1:89-100.
- 23. Nimish A. Mohile, MD, Lauren E. Abrey, MD. Primary Central Nervous System Lymphoma//J Neurol Clin, 2007; 25:1193-1207.
- 24. O`Neill, B.P. and J.J. Illig. Primary central nervous system lymphoma//J Mayo Clin. Proc, 1989; 64:1005-1020.
- 25. O`Neill, B.P., J.R. O`Fallon, J.D. Earle et al. Primary central nervous system non-Hodgkin`s lymphoma: Survival advantages with combined initial therapy? //Int. J. Rad. Oncol. Biol. Physics, 1995; 33:63-673.
- 26. Omuro AMP, DeAngelis LM, Yahalom J, et al. Chemoradiotherapy for primary CNS lymphoma: an intent-to treat analysis with complete followup// J Neurology 2005;64(1):69-74.
- 27. Paulus W, Jellinger K. Comprasion of integrin adhesion molecules, expressed by primary brain lymphomas and nodal lymphomas//J Acta Neuropathol, 1993; 86: 360-364.
- 28. Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas// J Neurooncol, 1999; 43: 203-208.
- 29. Pollack, I.F., L.D. Lunsford, J.C. Flickinger et al. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma// J Cancer, 1989; 63:939-947.
- 30. Poormans PMP, Kluin-Nelemans HC, Haaxma- Reiche H, et al. High-dose methotrexatebased chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962// J Clin Oncol 2003;21(24): 4483-8.
- 31. Posner JB. Neurologic Complications of Cancer// Philadelphia, FA Davis Company, 1995.
- 32. Roelcke U, Leenders KL. Positron emission tomography in patients with primary CNS lymphomas//J Ann Hematol, 2001; 80(Suppl 3): B113-117.
- 33. Schabet M. Epidemiology of primary CNS lymphoma// J Neurooncol 1999;43(3): 199-201.
- 34. Shibamoto Y, Hayabuchi N, Hiratsuka J, et al. Is whole-brain irragiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation//J Cancer, 2003; 97:128-133.
- 35. Tarakad S Ramachandran, MBBS, FRCP(C), FACP. Primary CNS Lymphoma [webpage] - [visited 11.03.2013]: http://emedicine.medscape.com/ article/1157638-overview#aw2aab6b4
- 36. Todd FD, Miller CA, Yates AJ, et al. Steroid-induced remission in primary malignant lymphoma of central nervous system// J Surg Neurol 1986; 26(1): 79-84.
- 37. Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to highdose methotrexate// J Clin Oncol,1986; 4:1845-1850.
- 38. Zhang L, Zhang J, Lambert Q, Der CJ, Del Valle L, Miklossy J, Khalili K, Zhou Y, Pagano JS. Interferon regulatory factor 7 is associated with Epstein- Barr virus-transformed central nervous system lymphoma and has oncogenic properties// J Virol, 2004; 78: 12987-12995.